{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:55:06Z","timestamp":1790924106236,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.colsurfb.2019.05.057","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:22:28Z","timestamp":1558696948000},"page":"623-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis"],"prefix":"10.1016","volume":"181","author":[{"given":"Nabila A.","family":"El-Sheridy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa A.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-2778","authenticated-orcid":false,"given":"Amira A.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-8113","authenticated-orcid":false,"given":"Labiba K.","family":"El-Khordagui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2019.05.057_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/17425255.2018.1461834","article-title":"Common drug-drug interactions in antifungal treatments for superficial fungal infections","volume":"14","author":"Gupta","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2014.06.030","article-title":"Statistically designed nonionic surfactant vesicles for dermal delivery of itraconazole: characterization and in vivo evaluation using a standardized Tinea pedis infection model","volume":"472","author":"Kumar","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 1","key":"10.1016\/j.colsurfb.2019.05.057_bib0015","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/clinids\/9.Supplement_1.S15","article-title":"Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models","volume":"9","author":"Van Cutsem","year":"1987","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0020","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/03639045.2014.931966","article-title":"Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis","volume":"41","author":"Pal","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0025","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3109\/10717544.2014.942811","article-title":"Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle","volume":"23","author":"ElMeshad","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.colsurfb.2015.03.059","article-title":"Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis","volume":"130","author":"Jaiswal","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1166\/jbn.2018.2574","article-title":"In vivo vaginal fungal load reduction after treatment with itraconazole-loaded polycaprolactone-nanoparticles","volume":"14","author":"Lucena","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0040","doi-asserted-by":"crossref","DOI":"10.1089\/adt.2018.898","article-title":"Repositioning of itraconazole for the management of ocular neovascularization through surface-modified nanostructured lipid carriers","author":"Selvaraj","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2018.04.031","article-title":"Repurposing itraconazole to the benefit of skin cancer treatment: a combined azole-DDAB nanoencapsulation strategy","volume":"167","author":"Carbone","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0050","first-page":"S77","article-title":"Pilot study of topical itraconazole for the treatment of basal cell carcinomas in gorlin syndrome patients","volume":"138","author":"Kim","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","article-title":"Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0060","first-page":"1","article-title":"Innovative nanocompounds for cutaneous administration of classical antifungal drugs: a systematic review","author":"Santos","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2017.03.019","article-title":"Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges","volume":"523","author":"Soliman","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2017.09.031","article-title":"Recent advances in nanocarrier-loaded gels: Which drug delivery technologies against which diseases?","volume":"266","author":"Pitorre","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0075","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.xphs.2017.03.042","article-title":"Recent update on nanoemulgel as topical drug delivery system","volume":"106","author":"Choudhury","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","article-title":"Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study","volume":"25","author":"El-Housiny","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejps.2014.10.014","article-title":"D-optimal experimental approach for designing topical microemulsion of itraconazole: characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats","volume":"67","author":"Kumar","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11046-014-9837-2","article-title":"Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis","volume":"179","author":"Leal","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0095","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/10837450.2014.882935","article-title":"Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery","volume":"20","author":"Mohanty","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0100","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3109\/10717544.2016.1153749","article-title":"A vaginal drug delivery model","volume":"23","author":"Mirza","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A novel phase inversion-based process for the preparation of lipid nanocarriers","volume":"19","author":"Heurtault","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0927-7765(03)00096-1","article-title":"Interfacial stability of lipid nanocapsules","volume":"30","author":"Heurtault","year":"2003","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijpharm.2012.06.019","article-title":"Evaluation of surface deformability of lipid nanocapsules by drop tensiometer technique, and its experimental assessment by dialysis and tangential flow filtration","volume":"434","author":"Hirsjarvi","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/nnm.14.124","article-title":"In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor","volume":"10","author":"Groo","year":"2015","journal-title":"Nanomed. Lond. (Lond)"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0125","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.2147\/IJN.S167285","article-title":"Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting","volume":"13","author":"Amara","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2019.02.013","article-title":"Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin","volume":"560","author":"Bapat","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141788","article-title":"Miltefosine lipid nanocapsules for single dose oral treatment of schistosomiasis mansoni: a preclinical study","volume":"10","author":"Eissa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejps.2018.05.016","article-title":"Acyclovir lipid nanocapsules gel for oromucosal delivery: a preclinical evidence of efficacy in the chicken pouch membrane model","volume":"121","author":"Abozaid","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0145","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.xphs.2016.06.025","article-title":"Qualitative and quantitative study of the potential of lipid nanocapsules of one hundred twenty nanometers for the topical administration of hydrophobic molecules","volume":"105","author":"Nguyen","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2017.11.023","article-title":"Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review","volume":"112","author":"Garces","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/2211738506666180913125918","article-title":"Skin Targeting of oxiconazole nitrate loaded nanostructured lipid-carrier gel for fungal infections","volume":"6","author":"Ranpise","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0160","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.2147\/IJN.S145695","article-title":"Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model","volume":"12","author":"Tian","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0165","first-page":"1049","article-title":"Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0170","first-page":"3269","article-title":"UV method development and validation of itraconazole in capsule dosage form","volume":"2","author":"Kumudhavalli","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4333\/KPS.2010.40.5.305","article-title":"Microemulsion-based hydrogel formulation of itraconazole for topical delivery","volume":"40","author":"Lee","year":"2010","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/02681219480000471","article-title":"A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs","volume":"32","author":"Maebashi","year":"1994","journal-title":"J. Med. Vet. Mycol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0185","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.chemphyslip.2012.01.006","article-title":"Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis","volume":"165","author":"Gupta","year":"2012","journal-title":"Chem. Phys. Lipids"},{"issue":"6","key":"10.1016\/j.colsurfb.2019.05.057_bib0190","first-page":"1","article-title":"Animal models for candidiasis","volume":"105","author":"Conti","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0195","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0190-9622(99)70391-9","article-title":"Diagnosis of onychomycosis made simple","volume":"40","author":"Ellis","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13693780802245474","article-title":"Pseudohypha budding patterns of Candida albicans","volume":"47","author":"Veses","year":"2009","journal-title":"Med. Mycol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: a new platform for nanomedicine","volume":"379","author":"Huynh","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02652040500162436","article-title":"SLN and NLC for topical delivery of ketoconazole","volume":"22","author":"Souto","year":"2005","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2011.01.021","article-title":"Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration","volume":"79","author":"Roger","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2019.04.005","article-title":"An ex vivo evaluation of moxifloxacin nanostructured lipid carrier enriched in situ gel for transcorneal permeation on goat cornea","author":"Gade","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s13346-015-0263-x","article-title":"Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete\u2019s foot","volume":"6","author":"Singh","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejpb.2017.04.012","article-title":"Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery","volume":"117","author":"Noor","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2016.12.043","article-title":"Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide","volume":"518","author":"Hatahet","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0240","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.2147\/IJN.S146740","article-title":"Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats","volume":"12","author":"Hureaux","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejpb.2016.07.018","article-title":"Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons","volume":"108","author":"Pardeike","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics10020053","article-title":"Polymer-surfactant system based amorphous solid dispersion: Precipitation inhibition and bioavailability enhancement of itraconazole","volume":"10","author":"Feng","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2010.02.001","article-title":"In vitro drug release mechanism from lipid nanocapsules (LNC)","volume":"390","author":"Abdel-Mottaleb","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0260","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1166\/jnn.2007.18114","article-title":"Lipid nanocapsules for intracellular drug delivery of anticancer drugs","volume":"7","author":"Lacoeuille","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","volume":"419","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0270","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03639045.2017.1391832","article-title":"Development and in vitro\/in vivo evaluation of HPMC\/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent","volume":"44","author":"Varshosaz","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1208\/s12249-017-0811-4","article-title":"Design and development of repaglinide microemulsion gel for transdermal delivery","volume":"19","author":"Shinde","year":"2018","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0280","unstructured":"Kisak, E. and J. Singh, Diclofenac topical formulation, United States patent, US 20080300311A1 (2014)."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0285","first-page":"910","article-title":"Formulation and evaluation of mucoadhesive vaginal gel containing novel combination of metronidazole and miconazole nitrate for the treatment of vaginitis","volume":"3","author":"Mundhey","year":"2015","journal-title":"World J. Pharmaceut. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0290","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.3390\/molecules17044612","article-title":"Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activity","volume":"17","author":"Winnicka","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0295","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2217\/nnm.11.35","article-title":"Size dependency of PLGA-nanoparticle uptake and antifungal activity against Aspergillus flavus","volume":"6","author":"Patel","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/08982101003596125","article-title":"Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis","volume":"20","author":"Gupta","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0305","first-page":"407","article-title":"Preparation and evaluation of clotrimazole nanostructured lipid carrier for topical delivery","volume":"4","author":"Shekhawat","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0310","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/1389201017666160301102459","article-title":"Nano-sized technologies for miconazole skin delivery","volume":"17","author":"Firooz","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2011.04.009","article-title":"Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers","volume":"79","author":"Abdel-Mottaleb","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2014.05.035","article-title":"Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation","volume":"471","author":"Zhai","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2019.05.057_bib0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/978-1-4612-2762-5_4","article-title":"Skin kinetics of azole antifungal drugs","volume":"4","author":"Cauwenbergh","year":"1992","journal-title":"Curr. Top. Med. Mycol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519303674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776519303674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:37:26Z","timestamp":1790923046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776519303674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":65,"alternative-id":["S0927776519303674"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.05.057","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Itraconazole lipid nanocapsules gel for dermatological applications: In vitro characteristics and treatment of induced cutaneous candidiasis","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2019.05.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}